UNIVERSITY OF ILLINOIS
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1859-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.illinois.edu
Clinical Trials
466
Active:32
Completed:244
Trial Phases
6 Phases
Early Phase 1:9
Phase 1:34
Phase 2:41
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (423 trials with phase data)• Click on a phase to view related trials
Not Applicable
307 (72.6%)Phase 2
41 (9.7%)Phase 1
34 (8.0%)Phase 4
21 (5.0%)Phase 3
11 (2.6%)Early Phase 1
9 (2.1%)Intraoperative Fluorescence-Guided Aspirate Tissue Monitoring of 5-ALA During Brain Tumor Surgery
Not Applicable
Not yet recruiting
- Conditions
- Brain Neoplasms
- First Posted Date
- 2025-08-08
- Last Posted Date
- 2025-08-08
- Lead Sponsor
- University of Illinois at Chicago
- Target Recruit Count
- 8
- Registration Number
- NCT07111182
Prison-Based HIV Partner Notification
Not Applicable
Not yet recruiting
- Conditions
- HIV
- First Posted Date
- 2025-08-05
- Last Posted Date
- 2025-08-05
- Lead Sponsor
- University of Illinois at Chicago
- Target Recruit Count
- 216
- Registration Number
- NCT07103928
- Locations
- 🇮🇩
Fakultas Ilmu Keperawatan, Universitas Indonesia, Depok, Jawa Barat, Indonesia
Aging and Task-specific Training to Reduce Falls
Not Applicable
Recruiting
- Conditions
- Fall Prevention
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- University of Illinois at Chicago
- Target Recruit Count
- 315
- Registration Number
- NCT07094659
- Locations
- 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States
CBTi for the Treatment of Insomnia in Type 1 Diabetes
Not Applicable
Not yet recruiting
- Conditions
- Diabetes Mellitus Type 1Insomnia
- First Posted Date
- 2025-07-29
- Last Posted Date
- 2025-07-29
- Lead Sponsor
- University of Illinois at Chicago
- Target Recruit Count
- 15
- Registration Number
- NCT07091318
- Locations
- 🇺🇸
University of Illinois Chicago, Chicago, Illinois, United States
EEG Biomarkers for OUD: Diagnostic, Prognostic, and Predictive Applications
Recruiting
- Conditions
- Opiod Use Disorder
- First Posted Date
- 2025-07-25
- Last Posted Date
- 2025-07-25
- Lead Sponsor
- University of Illinois at Chicago
- Target Recruit Count
- 70
- Registration Number
- NCT07085351
- Locations
- 🇺🇸
Clinical & Imaging Research Outcomes Lab, Chicago, Illinois, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 94
- Next
News
Breakthrough in Platelet Engineering Opens New Avenues for Targeted Drug Delivery
University of Illinois researchers have successfully applied metabolic glycan labeling to platelets for the first time, overcoming the challenge of engineering these nucleus-free cell fragments.